Download presentation
Presentation is loading. Please wait.
1
Role of KMLTTB in HIV POC implementation
MINISTRY OF HEALTH Kenya Medical Lab Technicians and Technologists Board Role of KMLTTB in HIV POC implementation Bintiomar Tsala, Abdulatif ALI
2
Kenya; Point of Care testing
1st 90; Gap of 25% Opportunities for POC While Kenya has a robust HIV lab network POCT has been identified to address her unmet needs of HIV EID and Viral load testing. Centralized system 2nd 90; Gap of 20%
3
Key thematic areas for POC implementation
Key pillars that anchor POC implementation The process has taken into consideration PLHIV or at risk of HIV (HEI) as the central beneficiaries of POC. SOC has helped the country achieve “access to HIV diagnostics” with several great achievements and some recognized challenges like delays in TAT for testing or for receiving results. POC intends to complement the SOC in strengthening systems for HIV diagnostics but also contribute to the country’s “Results-4-life” initiative where the intention is to increase “Access to results” for timely clinical interventions
4
KMLTTB Function – Regulatory approvals
Ministry of Health Legal Notice 113 (2011) Manufacturers of IVD products approached relevant programs directly without proper verifications Mandated KMLTTB Regulation of all IVDs intended for laboratory use in Kenya KMLTTB function
5
Role of KMLTTB in POC implementation
Main Pre-distribution lot – to –lot validation Registration of the POC devices Post-market surveillance
6
Overview of POCs registration process
Training of ToT on POC usability Validation report from lab POC is returned to manufacturer Duly filled registration form Registration payment 5 Recommendation to manufacturer/ Certificate of approval Submission of form & Dossier to KMLTTB Submission of POC to KMLTTB POC released to validating lab
7
Validation outcomes of the two POC Technologies
WHO pre-qualified EID POC devices 1.Alere Q HIV 1/2 Detect 2. Genexpert HIV 1 Qual assay Parameter Alere Q GeneXpert Sensitivity 97.6% 99.1% Specificity 100% 98.9% PPV NPV 97.0% 98.1% Kappa 0.966 0.987 Errors 13.6% 4.2% The two equipment were duly registered
8
Pre-distribution - lot to lot validation
NHRL KMLTTB KEMSA
9
Post market surveillance
tool to consistently monitor the performance & quality of the reagent lots surveys on usability periodic reviews & reports from end users Electronic POC records to pull out data to understand the trends related to operation of the equipment Provides information on the safety of the POC devices/cartridges after it is used in the general or local population post-distribution
10
SWOT analysis of POC regulatory approval
Strengths Existent regulatory system established by law Existent national validation laboratories Accommodative national environment for multiple products to be validated and introduced into the market Threats Limited funding for post market surveillance . Training the laboratory personnel across the country on usability Weakness Lack of reference assays for emerging technologies National post-market surveillance policy framework for in-vitro diagnostic devices Opportunities Implementation of a fast tracking process for registration of WHO prequalified, CE marked, FDA or any other internationally acceptable/recognized quality mark for POCT Finalization of a national post-market surveillance policy and guidelines
11
Best practices for POC regulatory approvals
Memorandum of understanding with the validating labs Harmonized Stringent regulation policies in place Strategic information Successful validation of the POC equipment
12
Conclusions Disclaimer Thank you There was no conflict of interest
KMLTTB played a key role in the roadmap towards implementation of POC in Kenya Disclaimer There was no conflict of interest Thank you
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.